PATENT CLAIM ANALYSIS

Application Number: 16119306
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["548", "264200"]

Abstract:
The present application relates to solid state forms of a triazolone compound which exhibit mPGES-1 enzyme inhibition activity, specifically N-(4-chloro-3-(5-oxo-1-(4-(trifluoromethyl)phenyl)-4,5-dihydro-1H-1,2,4-triazol-3-yl)benzyl) pivalamide (Compound of formula II), and process for preparation thereof.

Claim (Index 41):
The process according to  claim 31 , wherein the reaction of step d) is carried out in the presence of a mixture of solvents.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 96.0
- Lexical Diversity: 1.25
- Patent Class: 548.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15573387', '15762523', '15919460', '14402608', '13060388']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7582903392457947
- 35 USC 102 Novelty (BERT): 0.5663916242628175
- Combined Prediction Score: 0.739100467747497
- Mean Citation Score: 292.5759520000001
- Max Citation Score: 537.5445599999998
- Similarity Product: 320.87495079151137

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test